期刊文献+

葡萄糖转运蛋白Ⅰ型与肿瘤增殖细胞核抗原在卵巢上皮性肿瘤中的表达及意义

Expression and Significance of Glucose Transporter 1 and Tumor Proliferating Karyon Antigen Ki-67 in Epithelial Ovarian Tumor
原文传递
导出
摘要 目的探讨葡萄糖转运蛋白Ⅰ型(glucose transporter 1,GLUT1)和肿瘤增殖细胞核抗原Ki-67在卵巢上皮性肿瘤组织中的表达及其临床意义。方法收集2000年1月2008年6月不同卵巢上皮性肿瘤病变患者119例的组织标本,采用免疫组织化学SP二步法检测肿瘤组织中GLUT1和Ki-67的表达情况。结果卵巢交界性、恶性上皮性肿瘤灶性或广泛高表达GLUT1和Ki-67,其表达强度有差异。卵巢良性上皮性肿瘤不表达GLUT1和Ki-67。在卵巢癌中GLUT1及Ki-67的表达强度与病理分级、临床分期、预后有关。GLUT1表达强度与病理分型无关,Ki-67表达强度与病理分型有关。结论卵巢上皮性肿瘤组织中GLUT1和Ki-67的表达具有相关性,其表达强度与肿瘤的良恶性质和增殖状态有关,二者同时检测可以全面了解卵巢上皮性肿瘤的性质、卵巢癌恶性程度和生物学行为,对于判断肿瘤的性质和预后有一定价值。 Objective To investigate the expression and clinical significance of glucose transporter-1(GLUT1) and tumor proliferating karyon antigen Ki-67 in epithelial ovarian tumor tissue.Methods Immunohistochemistry SP method was used to detect the expression of GLUT1 and Ki-67 protein in epithelial ovarian tumor tissues from 119 patients diagnosed in our hospital from January 2000 to June 2008.Results The expressions of GLUT1 and Ki-67 had local or abroad higher expressions in the borderline and malignant epithelial ovarian tumor,and the expressive intensity was different.In benign tumors,the expression was negative.The expressive intensity of GLUT1 and Ki-67 had correlation with the grade,stage,and prognosis in malignant tumors.The expressive intensity of GLUT1 had no correlation with the type of malignant tumors,while Ki-67 related to the pathological types.Conclusion The expressions of GLUT1 and Ki-67 have relativity.The expressive intensity of GLUT1 and Ki-67 relates to the character and proliferation of epithelial ovarian tumors.The combined detection GLUT1 and Ki-67 is helpful to know the character of epithelial ovarian tumors,the malignant degree and biologic behavior of ovarian carcinoma,which is useful in estimating the character and prognosis of epithelial ovarian tumors.
出处 《华西医学》 CAS 2011年第1期63-65,共3页 West China Medical Journal
关键词 卵巢上皮性肿瘤 葡萄糖转运蛋白Ⅰ型 肿瘤增殖细胞核抗原 预后 Epithelial ovarian tumor Glucose transporter 1 Tumor proliferating karyon antigen Prognosis
  • 相关文献

参考文献10

  • 1Rudlowski C, Moser M, Becker AJ, et al. GI.UT1 mRNA and protein expression in ovarian borderline tumors and caneer[J]. Oncology, 2004, 66(5):404-410.
  • 2Khouja MH, Baekelandt M, Nesland JM, et al. The clinical importance of Ki 67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma[J]. Int J Gynecol Pathol, 2007, 26(4): 418 -425.
  • 3Wood IS, Trayhum P. Glucose transporters (GLUT1 and SGLT) : expanded families of sugar transpost proteins[J]. Br J Nutr, 2003, 89(1): 3-9.
  • 4Younes M, Lechago LV, Somoano JR, el al. Wide expression of the human erythrocyte glucose transporter GLUT1 in human cancers[J]. Cancer Res, 1996, 56(5): 1164-1167.
  • 5蔡昱,邵淑丽.GLUT1研究进展[J].国际肿瘤学杂志,2004,31(S1):50-52. 被引量:3
  • 6Kalir T, Wang BY, Goldfischer M, et al. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia[J]. Cancer, 2002, 94(4): 1078 -1082.
  • 7Haber RS, Rathan A, Weiser KR, et al. GLUT1 glucose transporter expression in colorectal carcinoma.- a marker for poor prognosis[J]. Cancer, 1998, 83(1): 34 -40.
  • 8Cantuaria G, Magalhaes A, Angioli R, et al. Antitumor activity of a novel glyeco-nitric oxide conjugate in ovarian carcinoma [J]. Cancer, 2000, 88(2): 381-388.
  • 9颜琳,吴绪峰,陈惠祯.PTEN和Ki-67在上皮性卵巢癌中的表达及意义[J].现代肿瘤医学,2005,13(2):151-153. 被引量:4
  • 10任琼珍,钱志红,胡建铭.Ki67在卵巢癌中的表达及临床意义[J].苏州大学学报(医学版),2006,26(2):321-321. 被引量:9

二级参考文献33

  • 1贾学玲,高云荷,张煦.子宫内膜增生及内膜癌中PTEN、Ki-67蛋白的表达[J].临床与实验病理学杂志,2003,19(2):152-155. 被引量:19
  • 2McCormick D,Yu C,Hobbs C,et al.The relevance of antibody conecentration to the immunohistological quantiation of cell proliferation associated antigens[J].Histoparthology,1993,22:543-547.
  • 3Bravo R,macdonald-Bravo M.Existence of two popul-ations of cyclin/proliferating cell nuclear antigen during the cell cycle.Association with DNA replication sites[J].J Cell Biol,1987,105:1549-1554.
  • 4Stefansson IM,Salvesen HB,Immervoll H,et al.Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.Histopathology,2004,44(5):472-479.
  • 5Hartmann LC,Sebo TJ,Kamel NA,et al.Proliferating cell nuclear antigen in epithelial ovarian cancer:Relation to results of second-look laparotomy and survival[J].Gynecol Oncol,1992,47(2):191-195.
  • 6Goff BA,Ries JA,Els LP,et al.Immunophenotype of ovarian cancer as predictor of clinical outcome:evaluation at primary surgery and second-look procedure[J].Gynecol Oncol,1998,70(3):378-385.
  • 7Ali IU, Schriml LM, Dean M, et al. Mutational spectra of PTEN/ MMAC1 gene:a tumor suppressor with lipid phosphatase activity[J]. J Natl Cancer Inst, 1999,91:1922 ~ 1932.
  • 8Tashiro H,Blazes MS,Wu R,et al . Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies[J]. Cancer Res, 1997,57:3935 ~ 3940.
  • 9Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTENexpression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression,in primary epithelial ovarian carcinomas [J]. Am J Pathol,2001,158 :2097 ~ 2106.
  • 10Li J,Yen C,Liaw D,et al. PTEN,a putative protein ryrosine phosphatase gene mutated in human brain, breast and prostate cancer.Science[J], 1997, 275:1876 - 1879,1943~1947.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部